Senseonics Holdings, Inc. (SENS)

USD 0.41

(-3.22%)

Market Cap (In USD)

241.7 Million

Revenue (In USD)

22.39 Million

Net Income (In USD)

-60.39 Million

Avg. Volume

3.2 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.25-0.75
PE
-
EPS
-
Beta Value
0.795
ISIN
US81727U1051
CUSIP
81727U105
CIK
1616543
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Timothy T. Goodnow Ph.D.
Employee Count
-
Website
https://www.senseonics.com
Ipo Date
2015-12-22
Details
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.